Literature DB >> 31511943

Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism.

Claire E Graves1, Catherine M McManus1, John A Chabot1, James A Lee1, Jennifer H Kuo2.   

Abstract

BACKGROUND: Recently, normocalcemic (NC) and normohormonal (NH) variants of primary hyperparathyroidism (pHPT) have been described, with distinct biochemical profiles from the typical high serum calcium and parathyroid hormone (PTH) levels. Here, we investigate whether biochemical profile affects cure rate, as well as the kinetics of intraoperative PTH (IOPTH).
METHODS: This is a single-center, retrospective study of pHPT patients undergoing parathyroidectomy. Patients were grouped based on preoperative calcium and PTH levels into typical, NC (normal calcium, elevated PTH, no evidence of secondary hyperparathyroidism), and NH (elevated calcium, unsuppressed PTH) biochemical profiles. All patients had IOPTH monitoring and ≥6-month post-op serum studies to confirm surgical cure. Patient variables were analyzed with Kruskal-Wallis test and Chi-square analysis. IOPTH kinetic curves were analyzed using a linear mixed model.
RESULTS: From June 2006 to October 2014, 646 patients met inclusion criteria. Biochemical profile was typical in 460 patients (71%), NC in 101 (16%), and NH in 85 (13%). IOPTH levels were higher at all time points in typical patients, p < 0.001. Surgical cure rates were significantly lower for NC patients (90.1%) than for typical (98.5%) or NH patients (97.7%), p < 0.001, although a stricter criteria for cure was used in this group (normal calcium AND normal PTH). In a multivariable linear mixed model, NC patients had a significantly slower rate of IOPTH decline (p < 0.001 at 10 min).
CONCLUSIONS: Here, we better characterize the atypical variants of pHPT. Using a stricter definition of cure in the NC variant, these patients have a lower surgical cure rate than typical or NH variants in pHPT. The IOPTH curve is affected by biochemical profile, with both NC and NH patients having lower absolute values and NC patients having a slower decline.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31511943     DOI: 10.1007/s00268-019-05157-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  28 in total

1.  National trends in parathyroid surgery from 1998 to 2008: a decade of change.

Authors:  Andrew B Greene; Robert S Butler; Shannon McIntyre; German F Barbosa; Jamie Mitchell; Eren Berber; Allan Siperstein; Mira Milas
Journal:  J Am Coll Surg       Date:  2009-09       Impact factor: 6.113

2.  The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study.

Authors:  Janice L Pasieka; Louise Parsons; Jean Jones
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

3.  Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.

Authors:  Shonan Sho; Eric J Kuo; Angela C Chen; Ning Li; Michael W Yeh; Masha J Livhits
Journal:  Ann Surg Oncol       Date:  2018-11-07       Impact factor: 5.344

4.  An optimal algorithm for intraoperative parathyroid hormone monitoring.

Authors:  Melanie L Richards; Geoffrey B Thompson; David R Farley; Clive S Grant
Journal:  Arch Surg       Date:  2011-03

5.  Bone mineral density changes after parathyroidectomy are dependent on biochemical profile.

Authors:  Denise Lee; Marcella D Walker; Hsin Yi Chen; John A Chabot; James A Lee; Jennifer H Kuo
Journal:  Surgery       Date:  2018-10-14       Impact factor: 3.982

6.  Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism.

Authors:  Gina Trinh; Salem I Noureldine; Jonathon O Russell; Nishant Agrawal; Michael Lopez; Jason D Prescott; Martha A Zeiger; Ralph P Tufano
Journal:  Surgery       Date:  2016-11-15       Impact factor: 3.982

7.  Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism.

Authors:  Megan K Applewhite; Michael G White; Jennifer Tseng; Maryam K Mohammed; Frederic Mercier; Edwin L Kaplan; Peter Angelos; Tamara Vokes; Raymon H Grogan
Journal:  Surgery       Date:  2016-11-17       Impact factor: 3.982

8.  Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study).

Authors:  Karolina Lundstam; Ansgar Heck; Kristin Godang; Charlotte Mollerup; Marek Baranowski; Ylva Pernow; Turid Aas; Ola Hessman; Thord Rosén; Jörgen Nordenström; Svante Jansson; Mikael Hellström; Jens Bollerslev
Journal:  J Bone Miner Res       Date:  2017-07-07       Impact factor: 6.741

9.  Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome.

Authors:  George L Irvin; Carmen C Solorzano; Denise M Carneiro
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

Review 10.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

View more
  4 in total

1.  Biochemical Profile Affects IoPTH Kinetics and Cure Rate in Primary Hyperparathyroidism.

Authors:  F Fausto Palazzo
Journal:  World J Surg       Date:  2020-02       Impact factor: 3.352

2.  Comparison between Second- and Third-Generation PTH Assays during Minimally Invasive Parathyroidectomy (MIP).

Authors:  Marie-Hélène Gannagé-Yared; Nada Younès; Anne-Sophie Azzi; Ghassan Sleilaty
Journal:  Int J Endocrinol       Date:  2020-03-16       Impact factor: 3.257

3.  Intraoperative parathormone monitoring to predict operative success in patients with normohormonal hyperparathyroidism.

Authors:  Heather Stuart; Basem Azab; Omar Picado Roque; Janice Pasieka; John I Lew
Journal:  Can J Surg       Date:  2022-07-28       Impact factor: 2.840

Review 4.  Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach.

Authors:  Guido Zavatta; Bart L Clarke
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.